Clarity Pharmaceuticals Ltd.ASX: CU6

SARTATE Neuroblastoma trial advances to cohort 2

Feb 1, 2022 at 4:02 AM UTC · Issued by Clarity Pharmaceuticals Ltd.

Clarity Pharmaceuticals Ltd has released a press release.

View Attachment